HPV-16 and -18 L1 VLP vaccine

Details for Australian Patent Application No. 2003293942 (hide)

Owner GlaxoSmithKline Biologicals SA

Inventors Slaoui, Moncef Mohammed; Wettendorff, Martine Anne Cecile; Innis, Bruce; Dubin, Gary

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2003293942

PCT Number PCT/EP2003/0145

PCT Pub. Number WO2004/056389

Priority 60/496,653 20.08.03 US; 60/435,035 20.12.02 US

Filing date 18 December 2003

Wipo publication date 14 July 2004

Acceptance publication date 10 December 2009

International Classifications

A61K 39/12 (2006.01) Medicinal preparations containing antigens or antibodies - Viral antigens

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 60/496,653 20.08.03 US; 60/435,035 20.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003293942

10 December 2009 Application Accepted

  Published as AU-B-2003293942

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003293943-Steroid compounds with anti-tumor activity

2003293941-SYSTEM FOR ESTIMATION AND CONTROL OF THE CONCENTRATIONS OF POLLUTANT GASES AT THE DISCHARGE OF A GAS TURBINE